Berberine: A fluorescent alkaloid with a variety of applications from medicine to chemistry

Mini-Reviews in Organic Chemistry

Volumn 7, Issue 4, 2010, Pages 335-340

  Domingo, M P ^a   Pardo, J ^b,c   Cebolla, V ^a   Gálvez, Eva M ^a  

^a INSTITUTO DE CARBOQUÍMICA   (Spain)

^b UNIVERSITY OF ZARAGOZA   (Spain)

^c FUNDACIÓN ARAID   (Spain)

Author keywords

Alkaloid; Analysis; Berberine; Biochemistry; Fluorescent; Medicine

Indexed keywords

ANTIMICROBIAL AGENTS; DISEASES; FLUORESCENCE; MEDICAL APPLICATIONS; METABOLITES; PROTEINS;

ANALYSE; BERBERINE; CHINESE HERBAL MEDICINES; FLUORESCENT; FLUORESCENT PROPERTY; GASTRIC DISEASE; INFLAMMATORY DISEASE; PROPERTY; PROTEIN CONFORMATION; PROTEIN-PROTEIN INTERACTIONS;

ALKALOIDS;

EID: 77958167483     PISSN: 1570193X     EISSN: None     Source Type: Journal    
DOI: 10.2174/157019310792246445     Document Type: Article

References (88)

1. Imanshahidi, M.; Hosseinzadeh, H. Pharmacological and therapeutic effects of Berberis vulgaris and its active constituent, berberine. Phytother. Res. 2008, 22(8), 999-1012.
2. Pan, L. R.; Tang, Q.; Fu, Q.; Hu, B. R.; Xiang, J. Z.; Qian, J. Q. Roles of nitric oxide in protective effect of berberine in ethanol-induced gastric ulcer mice. Acta Pharmacol. Sin. 2005, 26(11), 1334-1338.
3. Kong, W.; Wei, J.; Abidi, P.; Lin, M.; Inaba, S.; Li, C.; Wang, Y.; Wang, Z.; Si, S.; Pan, H.; Wang, S.; Wu, J.; Li, Z.; Liu, J.; Jiang, J. D. Berberine is a novel cholesterol-lowering drug working through a unique mechanism distinct from statins. Nat. Med. 2004, 10(12), 1344-1351.
4. Yin, J.; Hu, R.; Chen, M.; Tang, J.; Li, F.; Yang, Y.; Chen, J. Effects of berberine on glucose metabolism in vitro. Metabolism 2002, 51(11), 1439-1443.
5. Li, Y. H.; Yang, P.; Kong, W. J.; Wang, Y. X.; Hu, C. Q.; Zuo, Z. Y.; Wang, Y. M.; Gao, H.; Gao, L. M.; Feng, Y. C.; Du, N. N.; Liu, Y.; Song, D. Q.; Jiang, J. D. Berberine analogues as a novel class of the low-density-lipoprotein receptor up-regulators: synthesis, structure-activity relationships, and cholesterol-lowering efficacy. J. Med. Chem. 2009, 52(2), 492-501.
6. Jiang, J. D.; Kong, W. J.; Zhao, L. X.; Song, D. Q. Methods and compositions using berberine compounds for the treatment of hyperlipidemia, elevated cholesterol, and/or cardiovascular disease. PCT Int. Appl 2006, WO 43964.
7. Jia, X.; Chen, Y.; Zidichouski, J.; Zhang, J.; Sun, C.; Wang, Y. Coadministration of berberine and plant stanols synergistically reduces plasma cholesterol in rats. Atherosclerosis 2008, 201(1), 101-7.
8. Issat, T.; Jakobisiak, M.; Golab, J. Berberine, a natural cholesterol reducing product, exerts antitumor cytostatic/cytotoxic effects independently from the mevalonate pathway. Oncol. Rep. 2006, 16(6), 1273-6.
9. Doggrell, S. A. Berberine--a novel approach to cholesterol lowering. Expert Opin. Investig. Drugs 2005, 14(5), 683-5.
10. Abidi, P.; Chen, W.; Kraemer, F. B.; Li, H.; Liu, J. The medicinal plant goldenseal is a natural LDL-lowering agent with multiple bioactive components and new action mechanisms. J. Lipid. Res. 2006, 47(10), 2134-47.
11. Morel, C.; Stermitz, F. R.; Tegos, G.; Lewis, K. Isoflavones as potentiators of antibacterial activity. J. Agric. Food Chem. 2003, 51(19), 5677-9.
12. Cernakova, M.; Kostalova, D. Antimicrobial activity of berberine-a constituent of Mahonia aquifolium. Folia Microbiol. (Praha) 2002, 47(4), 375-8.
13. Freile, M. L.; Giannini, F.; Pucci, G.; Sturniolo, A.; Rodero, L.; Pucci, O.; Balzareti, V.; Enriz, R. D. Antimicrobial activity of aqueous extracts and of berberine isolated from Berberis heterophylla. Fitoterapia 2003, 74(7-8), 702-5.
14. Cossio, F. P.; Arrieta, A.; Cebolla, V. L.; Membrado, L.; Vela, J.; Garriga, R.; Domingo, M. P. Berberine cation: A fluorescent chemosensor for alkanes and other low-polarity compounds. An explanation of this phenomenon. Org. Lett. 2000, 2(15), 2311-3.
15. Cossio, F. P.; Arrieta, A.; Cebolla, V. L.; Membrado, L.; Domingo, M. P.; Henrion, P.; Vela, J. Enhancement of fluorescence in thin-layer chromatography induced by the interaction between n-alkanes and an organic cation. Anal. Chem. 2000, 72(8), 1759-66.
16. Galvez, E. M.; Matt, M.; Cebolla, V. L.; Fernandes, F.; Membrado, L.; Cossio, F. P.; Garriga, R.; Vela, J.; Guermouche, M. H. General contribution of nonspecific interactions to fluorescence intensity. Anal. Chem. 2006, 78(11), 3699-705.
17. Kuo, C. L.; Chi, C. W.; Liu, T. Y. The anti-inflammatory potential of berberine in vitro and in vivo. Cancer Lett. 2004, 203(2), 127-37.
18. Stermitz, F. R.; Scriven, L. N.; Tegos, G.; Lewis, K. Two flavonols from Artemisa annua which potentiate the activity of berberine and norfloxacin against a resistant strain of Staphylococcus aureus. Planta Med. 2002, 68(12), 1140-1.
19. Jang, C. G.; Lee, S. Y. Medicament component of berberine for the use of prevention and treatment of psychological dependence on and analgesic tolerance to morphine. PCT Int. Appl. 2004, WO 039372.
20. Asai, M.; Iwata, N.; Yoshikawa, A.; Aizaki, Y.; Ishiura, S.; Saido, T. C.; Maruyama, K. Berberine alters the processing of Alzheimer's amyloid precursor protein to decrease Abeta secretion. Biochem. Biophys. Res. Commun. 2007, 352(2), 498-502.
21. Zhu, F.; Qian, C. Berberine chloride can ameliorate the spatial memory impairment and increase the expression of interleukin-1beta and inducible nitric oxide synthase in the rat model of Alzheimer's disease. BMC Neurosci. 2006, 7, 78.
22. Zhou, X. Q.; Zeng, X. N.; Kong, H.; Sun, X. L. Neuroprotective effects of berberine on stroke models in vitro and in vivo. Neurosci. Lett. 2008, 447(1), 31-6.
23. Bashmakova, N.; Kutovyy, S.; Yashchuk, V.; Hovorun, D.; Losytskyy, M.; Zaika, L. Optical Spectroscopy studies of the interaction between a number of plant alkaloids and the DNA double Helix in an Aqueous solution. Ukranian J. Phys. 2009, 54(5), 471-479.
24. Liu, Z.; Liu, Q.; Xu, B.; Wu, J.; Guo, C.; Zhu, F.; Yang, Q.; Gao, G.; Gong, Y.; Shao, C. Berberine induces p53-dependent cell cycle arrest and apoptosis of human osteosarcoma cells by inflicting DNA damage. Mutat. Res. 2009, 662(1-2), 75-83.
25. Sun, Y.; Xun, K.; Wang, Y.; Chen, X. A systematic review of the anticancer properties of berberine, a natural product from Chinese herbs. Anticancer Drugs 2009, 20(9), 757-69.
26. Tang, J.; Feng, Y.; Tsao, S.; Wang, N.; Curtain, R.; Wang, Y. Berberine and Coptidis rhizoma as novel antineoplastic agents: a review of traditional use and biomedical investigations. J. Ethnopharmacol. 2009, 126(1), 5-17.
27. Hara, A.; Iizuka, N.; Hamamoto, Y.; Uchimura, S.; Miyamoto, T.; Tsunedomi, R.; Miyamoto, K.; Hazama, S.; Okita, K.; Oka, M. Molecular dissection of a medicinal herb with anti-tumor activity by oligonucleotide microarray. Life Sci. 2005, 77(9), 991-1002.
28. Adams, J. M.; Cory, S. The Bcl-2 apoptotic switch in cancer development and therapy. Oncogene 2007, 26(9), 1324-37.
29. Krammer, P. H. CD95(APO-1/Fas)-mediated apoptosis: live and let die. Adv. Immunol. 1999, 71, 163-210.
30. Hsu, W. H.; Hsieh, Y. S.; Kuo, H. C.; Teng, C. Y.; Huang, H. I.; Wang, C. J.; Yang, S. F.; Liou, Y. S.; Kuo, W. H. Berberine induces apoptosis in SW620 human colonic carcinoma cells through generation of reactive oxygen species and activation of JNK/p38 MAPK and FasL. Arch. Toxicol. 2007, 81(10), 719-28.
31. Hwang, J. M.; Kuo, H. C.; Tseng, T. H.; Liu, J. Y.; Chu, C. Y. Berberine induces apoptosis through a mitochondria/caspases pathway in human hepatoma cells. Arch. Toxicol. 2006, 80(2), 62-73.
32. Kim, S.; Choi, J. H.; Kim, J. B.; Nam, S. J.; Yang, J. H.; Kim, J. H.; Lee, J. E. Berberine suppresses TNF-alpha-induced MMP-9 and cell invasion through inhibition of AP-1 activity in MDA-MB-231 human breast cancer cells. Molecules 2008, 13(12), 2975-85.
33. Lin, J. P.; Yang, J. S.; Wu, C. C.; Lin, S. S.; Hsieh, W. T.; Lin, M. L.; Yu, F. S.; Yu, C. S.; Chen, G. W.; Chang, Y. H.; Chung, J. G. Berberine induced down-regulation of matrix metalloproteinase-1, -2 and -9 in human gastric cancer cells (SNU-5) in vitro. In Vivo 2008, 22(2), 223-30.
34. Ho, Y. T.; Yang, J. S.; Li, T. C.; Lin, J. J.; Lin, J. G.; Lai, K. C.; Ma, C. Y.; Wood, W. G.; Chung, J. G. Berberine suppresses in vitro migration and invasion of human SCC-4 tongue squamous cancer cells through the inhibitions of FAK, IKK, NF-kappaB, u-PA and MMP-2 and -9. Cancer Lett. 2009, 279(2), 155-62.
35. Tsang, C. M.; Lau, E. P.; Di, K.; Cheung, P. Y.; Hau, P. M.; Ching, Y. P.; Wong, Y. C.; Cheung, A. L.; Wan, T. S.; Tong, Y.; Tsao, S. W.; Feng, Y. Berberine inhibits Rho GTPases and cell migration at low doses but induces G2 arrest and apoptosis at high doses in human cancer cells. Int. J. Mol. Med. 2009, 24(1), 131-8.
36. Yu, F. S.; Yang, J. S.; Lin, H. J.; Yu, C. S.; Tan, T. W.; Lin, Y. T.; Lin, C. C.; Lu, H. F.; Chung, J. G. Berberine inhibits WEHI-3 leukemia cells in vivo. In Vivo 2007, 21(2), 407-12.
37. Letasiova, S.; Jantova, S.; Cipak, L.; Muckova, M. Berberineantiproliferative activity in vitro and induction of apoptosis/necrosis of the U937 and B16 cells. Cancer Lett. 2006, 239(2), 254-62.
38. Peng, P. L.; Kuo, W. H.; Tseng, H. C.; Chou, F. P. Synergistic tumor-killing effect of radiation and berberine combined treatment in lung cancer: the contribution of autophagic cell death. Int. J. Radiat. Oncol. Biol. Phys. 2008, 70(2), 529-42.
39. Katiyar, S. K.; Meeran, S. M.; Katiyar, N.; Akhtar, S. p53 Cooperates berberine-induced growth inhibition and apoptosis of non-small cell human lung cancer cells in vitro and tumor xenograft growth in vivo. Mol. Carcinog. 2009, 48(1), 24-37.
40. Ho, Y. T.; Yang, J. S.; Lu, C. C.; Chiang, J. H.; Li, T. C.; Lin, J. J.; Lai, K. C.; Liao, C. L.; Lin, J. G.; Chung, J. G. Berberine inhibits human tongue squamous carcinoma cancer tumor growth in a murine xenograft model. Phytomedicine 2009, 16(9), 887-90.
41. Choi, M. S.; Oh, J. H.; Kim, S. M.; Jung, H. Y.; Yoo, H. S.; Lee, Y. M.; Moon, D. C.; Han, S. B.; Hong, J. T., Berberine inhibits p53-dependent cell growth through induction of apoptosis of prostate cancer cells. Int. J. Oncol. 2009, 34(5), 1221-30.
42. Anis, K. V.; Rajeshkumar, N. V.; Kuttan, R. Inhibition of chemical carcinogenesis by berberine in rats and mice. J. Pharm. Pharmacol. 2001, 53(5), 763-8.
43. Harikumar, K. B.; Kuttan, G.; Kuttan, R. Inhibition of progression of erythroleukemia induced by Friend virus in BALB/c mice by natural products-berberine, curcumin and picroliv. J. Exp. Ther. Oncol. 2008, 7(4), 275-84.
44. Ckless, K.; Schlottfeldt, J. L.; Pasqual, M.; Moyna, P.; Henriques, J. A.; Wajner, M. Inhibition of in-vitro lymphocyte transformation by the isoquinoline alkaloid berberine. J. Pharm. Pharmacol. 1995, 47(12A), 1029-31.
45. Miura, N.; Yamamoto, M.; Ueki, T.; Kitani, T.; Fukuda, K.; Komatsu, Y. Inhibition of thymocyte apoptosis by berberine. Biochem. Pharmacol. 1997, 53(9), 1315-22.
46. Kang, B. Y.; Chung, S. W.; Cho, D.; Kim, T. S. Involvement of p38 mitogen-activated protein kinase in the induction of interleukin-12 p40 production in mouse macrophages by berberine, a benzodioxoloquinolizine alkaloid. Biochem. Pharmacol. 2002, 63(10), 1901-10.
47. Kim, T. S.; Kang, B. Y.; Cho, D.; Kim, S. H. Induction of interleukin-12 production in mouse macrophages by berberine, a benzodioxoloquinolizine alkaloid, deviates CD4+ T cells from a Th2 to a Th1 response. Immunology 2003, 109(3), 407-14.
48. Krey, A. K.; Hahn, F. E. Berberine: complex with DNA. Science 1969, 166(906), 755-7.
49. Hirakawa, K.; Kawanishi, S.; Hirano, T. The mechanism of guanine specific photooxidation in the presence of berberine and palmatine: activation of photosensitized singlet oxygen generation through DNA-binding interaction. Chem. Res. Toxicol. 2005, 18(10), 1545-52.
50. Ovadekova, R.; Jantova, S.; Letasiova, S.; Stepanek, I.; Labuda, J. Nanostructured electrochemical DNA biosensors for detection of the effect of berberine on DNA from cancer cells. Anal. Bioanal. Chem. 2006, 386(7-8), 2055-62.
51. Yu, C.; Hong, Y.; Zhang, H., Analysis for berberine by a sensitive high performance liquid chromatographic method. Chin. J. Chromatogr. 1994, 12, 37-39.
52. Yu, J. S.; Wei, F. D.; Gao, W.; Zhao, C. C. Thermodynamic study on the effects of beta-cyclodextrin inclusion with berberine. Spectrochim. Acta A Mol. Biomol. Spectrosc. 2002, 58(2), 249-56.
53. Megyesi, M.; Biczók, L.; Jablonkai, I. Highly sensitive fluorescence response to inclusion complex formation of berberine alkaloid with cucurbit[ 7]uril. J. Phys. Chem. C 2008, 112(9), 3410-3416.
54. Iwunze, M. O. Media influence on the enhancement of the fluorescence of berberine hydrochloride. Monatsh. Chem. 2000, 131, 429-435.
55. Iwunze, M. O. Fluorescence quenching of berberine hydrochloride by SDS in ethanolic solution. Spectroscopy 2001, 16, 14-22.
56. Wang, Y.; Liu, W.; Wang, K.; Shen, G.; Yu, R. Q. Optical fiber sensor for berberine based on fluorescence quenching of 2-(4-diphenylyl)-6-phenylbenzoxazole. Fresenius J. Anal. Chem. 1998, 36(6), 702-706.
57. Liu, W. H.; Wang, Y.; Tang, J. H.; Shen, G. L.; Yu, R. Q. An optical fiber sensor for berberine based on immobilized 1,4-bis(naphth[2,1-d]oxazole-2-yl)benzene in a new copolymer. Talanta 1998, 46(4), 679-88.
58. Wang, H.; Zhang, M.; Lv, Q.; Yue, N.; Gong, B. Determination of berberine and the study of fluorescence quenching mechanism between berberine and enzyme-catalyzed product. Spectrochim. Acta A Mol. Biomol. Spectrosc. 2009, 73(4), 682-6.
59. Hua, W.; Ding, L.; Chen, Y.; Gong, B.; He, J.; Xu, G. Determination of berberine in human plasma by liquid chromatography-electrospray ionizationmass spectrometry. J. Pharm. Biomed. Anal. 2007, 44(4), 931-7.
60. Zuo, F.; Nakamura, N.; Akao, T.; Hattori, M. Pharmacokinetics of berberine and its main metabolites in conventional and pseudo germ-free rats determined by liquid chromatography/ion trap mass spectrometry. Drug Metab. Dispos. 2006, 34(12), 2064-72.
61. Gupta, P. K.; Hubbard, M.; Gurley, B.; Hendrickson, H. P. Validation of a liquid chromatography-tandem mass spectrometric assay for the quantitative determination of hydrastine and berberine in human serum. J. Pharm. Biomed. Anal. 2009, 49(4), 1021-6.
62. Kratochwil, N. A.; Huber, W.; Muller, F.; Kansy, M.; Gerber, P. R. Predicting plasma protein binding of drugs--revisited. Curr. Opin. Drug Discov. Dev. 2004, 7(4), 507-12.
63. Hu, Y. J.; Liu, Y.; Xiao, X. H. Investigation of the interaction between berberine and Human Serum Albumin. Biomacromolecules 2009, 10(3), 517-521.
64. Jamur, M. C.; Lunardi, L. O.; Vugman, I. Mast cell maturation in young rats: a histofluorescence and cytochemical study. Acta Histochem. 1997, 99(4), 379-89.
65. MacDonald, A. J.; Thornton, E. M.; Newlands, G. F.; Galli, S. J.; Moqbel, R.; Miller, H. R. Rat bone marrow-derived mast cells co-cultured with 3T3 fibroblasts in the absence of T-cell derived cytokines require stem cell factor for their survival and maintain their mucosal mast cell-like phenotype. Immunology 1996, 88(3), 375-83.
66. Pang, X.; Letourneau, R.; Rozniecki, J. J.; Wang, L.; Theoharides, T. C. Definitive characterization of rat hypothalamic mast cells. Neuroscience 1996, 73(3), 889-902.
67. Tsai, M.; Takeishi, T.; Thompson, H.; Langley, K. E.; Zsebo, K. M.; Metcalfe, D. D.; Geissler, E. N.; Galli, S. J. Induction of mast cell proliferation, maturation, and heparin synthesis by the rat c-kit ligand, stem cell factor. Proc. Natl. Acad. Sci. USA 1991, 88(14), 6382-6.
68. Enerback, L. Berberine sulfate binding to mast cell polyanions. Cytofluorometric method for the quantitation of heparin. Histochemistry 1972, 42, 301-313.
69. Mikes, V.; Dadak, V., Berberine derivatives as cationic fluorescent probes for the investigation of the energized state of mitochondria. Biochim. Biophys. Acta 1983, 723(2), 231-9.
70. Molero, M. L.; Stockert, J. C. Fluorescence reaction of chromatin and basophilic cytoplasm by berberine sulfate. Cell Mol. Biol. Incl. Cyto Enzymol. 1981, 27, (5), 523-5.
71. Moutschen, J.; Degraeve, N.; Moutschen-Dahmen, N. Chromosome fluorescence with berberine sulfate. Cytobiologie 1973, 8, 112-117.
72. Hadzhiolov, I. D.; Zvetkova, A. I. New nuclear fluorochromatic technique using berberine sulfate to the detection of cell maturity and malignization. Doklady Bolgarskoi Akademii Nauk 1972, 25, 1725-1726.
73. Kovar, J.; Skursky, L. Fluorescence study of liver-alcohol-dehydrogenase complexes with berberine and other ligands. Eur. J. Biochem. 1973, 40(1), 233-44.
74. Tan, Y.; Xie, J. A study of the interaction of human serum albumin with berberine hydrochloride by a fluorescence method. Zhongyao Zazhi 1996, 21, 175-177.
75. Ulrichova, J.; Kovar, J.; Simanek, V. Interaction of quaternary aromatic isoquinoline alkaloids with acetylcholinesterase from Electrophorus electricus. Collect. Czechoslovak Chem. Commun. 1985, 50, 978-983.
76. Mikes, V.; Kovar, J. Interaction of liposomes with homologous series of fluorescent berberine derivatives. New cationic probes for measuring membrane potential. Biochim. Biophys. Acta 1981, 640(1), 341-51.
77. Lee, S. H. Chemical compositions, their use as cytochemical agents and methods for the detection of steroid hormone receptors in human tissue. Eur. Patent Appl 1979, 46.
78. Megyesi, M.; Biczok, L. Berberine alkaloid as a sensitive fluorescent probe for bile salt aggregates. J. Phys. Chem. B 2007, 111(20), 5635-9.
79. Zhao, C.; Yu, J., Effects of media environment on fluorescence spectra of berberine. Yaowu Fenxi Zazhi 2000, 20, 109-11.
80. Jung, D. W.; Yoo, G. S.; Choi, J. K., Detection of DNA in agarose gels using berberine and Mordant Yellow 3R. Anal. Biochem. 1999, 272(2), 254-6.
81. Gong, G. Q.; Zong, Z. X.; Song, Y. M. Spectrofluorometric determination of DNA and RNA with berberine. Spectrochim. Acta A Mol. Biomol. Spectrosc. 1999, 55A(9), 1903-7.
82. Song, G.; Yaopeng, C.; He, Z.; Zeng, Y. Fluorescence spectra studies on the interaction of berberine with nucleic acid. Fenxi Huaxue 1999, 27, 44-46.
83. Li, W. Y.; Lu, H.; Xu, C. X.; Zhang, J. B.; Lu, Z. H. Spectroscopic and binding properties of berberine to DNA and its application to DNA detection. Spectrosc. Lett. 1998, 31, 1287-1298.
84. Li, W. Y.; Lu, H. The fluorescent reaction between berberine and DNA and the fluorometry of DNA. Microchem. J. 1998, 60, 84-88.
85. Wang, S. L.; Yu, J. S.; Zou, Y. Z. Spectroscopic studies on the interactions of Ag (I), Au (III) and Pt (IV) with DNA. Wuji Huaxue Xuebao 2002, 18, 665-670.
86. Zhu, J.; Zhang, J. J.; Chen, H.Y. Study of interaction of berberine with DNA in the presence of b-cyclodexan. Specrosc. Lett. 1998, 31, 1705-1718.
87. Waring, M. J. Complex formation between ethidium bromide and nucleic acids. J. Mol. Biol. 1965, 13(1), 269-82.
88. N. T. P. A. Ethidium Bromide: Genetic Toxicity, 2005. http://ntp.niehs.nih.gov/index 2009.